HAVCR1 and diabetic kidney disease: Our principal aim was to determine whether a panel of biomarkers that includes UfRBP4 (glomerular and tubular disfunction), KIM-1 (an early and widely recognized marker of tubular injury and DKD progression) and the three microRNAs, miR-155, miR-126 and miR-29b, might prove useful early renal biomarkers in a normoalbuminuric cohort of young diabetic patients, and if there is any correlate with diabetic control and disease duration.